[미국특허]
Expandable microspheres and process for producing the same
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
C08J-009/24
B01J-013/02
출원번호
US-0600986
(2000-07-25)
우선권정보
JP-0027801 (1998-01-26); JP-0373407 (1998-12-28)
국제출원번호
PCT/JP99/00239
(1999-01-22)
국제공개번호
WO99/37706
(1999-07-29)
발명자
/ 주소
Ejiri, Tetsuo
Asai, Genzo
Satake, Yoshikatsu
출원인 / 주소
Kureha Kagaku K.K.
대리인 / 주소
Dinsmore & Shohl LLP
인용정보
피인용 횟수 :
18인용 특허 :
3
초록▼
Foamable microspheres with a foaming agent enclosed in the shell of a polymer, wherein the average particle diameter of the microspheres is within a range of 3 to 100 μm, and the coefficient of variation of the particle diameter distribution thereof is at most 1.50%, and production process of foamab
Foamable microspheres with a foaming agent enclosed in the shell of a polymer, wherein the average particle diameter of the microspheres is within a range of 3 to 100 μm, and the coefficient of variation of the particle diameter distribution thereof is at most 1.50%, and production process of foamable microspheres by a suspension polymerization process.
대표청구항▼
Foamable microspheres with a foaming agent enclosed in the shell of a polymer, wherein the average particle diameter of the microspheres is within a range of 3 to 100 μm, and the coefficient of variation of the particle diameter distribution thereof is at most 1.50%, and production process of foamab
Foamable microspheres with a foaming agent enclosed in the shell of a polymer, wherein the average particle diameter of the microspheres is within a range of 3 to 100 μm, and the coefficient of variation of the particle diameter distribution thereof is at most 1.50%, and production process of foamable microspheres by a suspension polymerization process. 14-membered aromatic heterocyclic group containing 1 to 4 hetero atoms selected from the group consisting of nitrogen, oxygen and sulfur atoms in addition to carbon atoms, which group may be substituted by 1 to 5 substituents selected from the group consisting of halogen atoms, C1-3alkylenedioxy, nitro, cyano, optionally halogenated C1-6alkyl, optionally halogenated C3-6cycloalkyl, optionally halogenated C1-6alkoxy, optionally halogenated C1-6alkylthio, hydroxy, amino, mono-C1-6alkylamino, di-C1-6alkylamino, 5- to 7-membered saturated cyclic amino, formyl, carboxy, carbamoyl, C1-6alkyl-carbonyl, C1-6alkoxy-carbonyl, C6-10aryl-carbonyl, C6-10aryloxy-carbonyl, C7-16aralkyloxy-carbonyl, 5- or 6-membered heterocycle carbonyl, mono-C1-6alkyl-carbamoyl, di-C1-6alkyl-carbamoyl, C6-10aryl-carbamoyl, 5- or 6-membered heterocycle carbamoyl, C1-6alkylsulfonyl, C6-10arylsulfonyl, formylamino, C1-6alkyl-carboxamido, C6-10aryl-carboxamido, C1-6alkoxy-carboxamido, C1-6alkylsulfonylamino, C1-6alkyl-carbonyloxy, C6-10aryl-carbonyloxy, C1-6alkoxy-carbonyloxy, mono-C1-6alkyl-carbamoyloxy, di-C1-6alkyl-carbamoyloxy, C6-10aryl-carbamoyloxy, nicotinoyloxy and C6-10aryloxy; R8is (a) a hydrogen atom, (b) a C1-6alkyl, C2-6alkenyl, C2-6alkynyl, C3-6cycloalkyl being optionally condensed with one benzene ring, C6-14aryl or C7-19aralkyl group which may be substituted by 1 to 5 substituents selected from the group consisting of (1) halogen atoms, (2) C1-3alkylenedioxy, (3) nitro, (4) cyano, (5) optionally halogenated C1-6alkyl, (6) optionally halogenated C3-6cycloalkyl, (7) optionally halogenated C1-6alkoxy, (8) optionally halogenated C1-6alkylthio, (9) hydroxy, (10) amino, (11) mono-C1-6alkylamino, (12) di-C1-6alkylamino, (13) formyl, carboxy, carbamoyl, C1-6alkyl-carbonyl, C1-6alkoxy-carbonyl, C6-10aryl-carbonyl, C6-10aryloxy-carbonyl, C7-16aralkyloxy-carbonyl, 5- or 6-membered heterocycle carbonyl, mono-C1-6alkyl-carbamoyl, di-C1-6alkyl-carbamoyl, C6-10aryl-carbamoyl, 5- or 6-membered heterocycle carbamoyl, C1-6alkylsulfonyl or C6-10arylsulfonyl, (14) formylamino, C1-6alkyl-carboxamido, C6-10aryl-carboxamido, C1-6alkoxy-carboxamido or C1-6alkylsulfonylamino, (15) C1-6alkyl-carbonyloxy, C6-10aryl-carbonyloxy, C1-6alkoxy-carbonyloxy, mono-C1-6alkyl-carbamoyloxy, di-C1-6alkyl-carbamoyloxy, C6-10aryl-carbamoyloxy or nicotinoyloxy, (16) 5- to 7-membered saturated cyclic amino, (17) sulfo, (18) a phenyl or 5- or 6-membered aromatic heterocyclic group containing 1 to 4 hetero atoms selected from the group consisting of nitrogen, oxygen and sulfur atoms in addition to carbon atoms, each of which may be substituted by 1 to 5 substituents selected from the group consisting of halogen atoms, C1-3alkylenedioxy, nitro, cyano, optionally halogenated C1-6alkyl, optionally halogenated C3-6cycloalkyl, optionally halogenated C1-6alkoxy, optionally halogenated C1-6alkylthio, hydroxy, amino, mono-C1-6alkylamino, di-C1-6alkylamino, 5- to 7-membered saturated cyclic amino, formyl, carboxy, carbamoyl, C1-6alkyl-carbonyl, C1-6alkoxy-carbonyl, C6-10aryl-carbonyl, C6-10aryloxy-carbonyl, C7-16aralkyloxy-carbonyl, 5- or 6-membered heterocycle carbonyl, mono-C1-6alkyl- carbamoyl, di-C1-6alkyl-carbamoyl, C6-10aryl-carbamoyl, 5- or 6-membered heterocycle carbamoyl, C1-6alkylsulfonyl, C6-10arylsulfonyl, formylamino, C1-6alkyl-carboxamido, C6-10aryl-carboxamido, C1-6alkoxy-carboxamido, C1-6alkylsulfonylamino, C1-6alkyl-carbonyloxy, C6-10aryl-carbonyloxy, C1-6alkoxy-carbonyloxy, mono-C1-6alkyl-carbamoyloxy, di-C1-6alkyl-carbamoyloxy, C6-10aryl-carbamoyloxy, nicotinoyloxy and C6-10aryloxy, (19) an aromatic ring assembly group which is composed of two or three rings selected from the group consisting of a C6-14aromatic hydrocarbon, a C6-14quinone and a 5- to 14-membered aromatic heterocyclic ring containing 1 to 4 hetero atoms selected from the group consisting of nitrogen, sulfur and oxygen atoms in addition to carbon atoms, are directly bonded to each other via a single bond, and which group may be substituted by 1 to 5 substituents selected from the group consisting of halogen atoms, C1-3alkylenedioxy, nitro, cyano, optionally halogenated C1-6alkyl, optionally halogenated C3-6cycloalkyl, optionally halogenated C1-6alkoxy, optionally halogenated C1-6alkylthio, hydroxy, amino, mono-C1-6alkylamino, di-C1-6alkylamino, 5- to 7-membered saturated cyclic amino, formyl, carboxy, carbamoyl, C1-6alkyl-carbonyl, C1-6alkoxy-carbonyl, C6-10aryl-carbonyl, C6-10aryloxy-carbonyl, C7-16aralkyloxy-carbonyl, 5- or 6-membered heterocycle carbonyl, mono-C1-6alkyl-carbamoyl, di-C1-6alkyl-carbamoyl, C6-10aryl-carbamoyl, 5- or 6-membered heterocycle carbamoyl, C1-6alkylsulfonyl, C6-10arylsulfonyl, formylamino, C1-6alkyl-carboxamido, C6-10aryl-carboxamido, C1-6alkoxy-carboxamido, C1-6alkylsulfonylamino, C1-6alkyl-carbonyloxy, C6-10aryl-carbonyloxy, C1-6alkoxy-carbonyloxy, mono-C1-6alkyl-carbamoyloxy, di-C1-6alkyl-carbamoyloxy, C6-10aryl-carbamoyloxy, nicotinoyloxy and C6-10aryloxy, and (20) a fused bi- or tn-cyclic C10-14aryl or 9- to 14-membered aromatic heterocyclic group containing 1 to 4 hetero atoms selected from the group consisting of nitrogen, oxygen and sulfur atoms in addition to carbon atoms, which group may be substituted by 1 to 5 substituents selected from the group consisting of halogen atoms, C1-3alkylenedioxy, nitro, cyano, optionally halogenated C1-6alkyl, optionally halogenated C3-6cycloalkyl, optionally halogenated C1-6alkoxy, optionally halogenated C1-6alkylthio, hydroxy, amino, mono-C1-6alkylamino, di-C1-6alkylamino, 5- to 7-membered saturated cyclic amino, formyl, carboxy, carbamoyl, C1-6alkyl-carbonyl, C1-6alkoxy-carbonyl, C6-10aryl-carbonyl, C6-10aryloxy-carbonyl, C7-16aralkyloxy-carbonyl, 5- or 6-membered heterocycle carbonyl, mono-C1-6alkyl-carbamoyl, di-C1-6alkyl-carbamoyl, C6-10aryl-carbamoyl, 5- or 6-membered heterocycle carbamoyl, C1-6alkylsulfonyl, C6-10arylsulfonyl, formylamino, C1-6alkyl-carboxamido, C6-10aryl-carboxamido, C1-6alkoxy-carboxamido, C1-6alkylsulfonylamino, C1-6alkyl-carbonyloxy, C6-10aryl-carbonyloxy, C1-6alkoxy-carbonyloxy, mono-C1-6alkyl-carbamoyloxy, di-C1-6alkyl-carbamoyloxy, C6-10aryl-carbamoyloxy, nicotinoyloxy and C6-10aryloxy, or (c) formyl, carboxy, carbamoyl, C1-6alkyl-carbonyl, C1-6alkoxy-carbonyl, C6-10aryl-carbonyl, C6-10
Ambrose, Catherine G.; Clyburn, Terry A.; Mikos, Antonio G., Antibiotic microspheres for treatment and prevention of osteomyelitis and enhancement of bone regrowth.
Mohan, Krishna K.; Goliber, Cynthia A.; Hong, Yaoliang; Froass, Peter M.; Young, Herbert; Anderson, Dennis W.; Faber, Richard D., Compositions containing expandable microspheres and an ionic compound, as well as methods of making and using the same.
Hong, Yaoliang; Mohan, Kosaraju Krishna; Dimonie, Victoria Laurentia; Fagan, Mark Edward; Klein, Andrew; Daniels, Eric Scott; Boyars, Brian; Froass, Peter M.; Anderson, Christopher D.; Sudol, Edward David, Expandable microspheres and methods of making and using the same.
Hong, Yaoliang; Mohan, Kosaraju Krishna; Froass, Peter M.; Fagan, Mark; Anderson, Christopher D.; Boyars, Brian; Daniels, Eric Scott; Dimonie, Victoria Laurentia; Sudol, Edward David; Klein, Andrew, Expandable microspheres and methods of making and using the same.
Glorioso, Jr., Sammie J. (Joey); Burgess, James H.; Tang, Jiansheng; Dimonie, Victoria L.; Klein, Andrew, Expandable microspheres for foam insulation and methods.
Swerin, Agne; Herman, Michael; Song, Jay C; Yang, Sen; Lee, Peter F; Bednarik, Ladislav, Paper with improved stiffness and bulk and method for making same.
Swerin, Agne; Song, Jay C.; Bednarik, Ladislav; Lee, Peter F.; Herman, Michael C.; Yang, Sen, Paper with improved stiffness and bulk and method for making same.
Ejiri, Tetsuo; Matsuzaki, Mitsuhiro; Endo, Shunzo, Thermally foamable microsphere, production method thereof, use thereof, composition containing the same, and article.
Miki, Katsushi; Masuda, Toshiaki; Takahara, Ichiro; Fujie, Takashi; Yosejima, Ikuo, Thermo-expansive microspheres, their production process and their application.
Miki,Katsushi; Masuda,Toshiaki; Takahara,Ichiro; Fujie,Takashi; Yosejima,Ikuo, Thermo-expansive microspheres, their production process and their application.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.